Companies similar to BENITEC BIOPHARMA INC (BNTC)
Health Care · NASDAQ
BENITEC BIOPHARMA INC (BNTC)'s closest peers include Alnylam Pharmaceuticals (ALNY), ARROWHEAD PHARMACEUTICALS, INC. (ARWR), INTELLIA THERAPEUTICS INC (NTLA), EDITAS MEDICINE INC (EDIT) and CRISPR THERAPEUTICS AG (CRSP). This peer set is drawn from BNTC's enriched company profile and is informational only — not financial advice.
Similar companies
-
Alnylam PharmaceuticalsALNYHealth Care
Alnylam is a global leader in RNA interference therapeutics, pioneering a new class of genetic medicines to treat rare and serious diseases.
$271.37 (as of 2026-07-21) · market cap $36.2B
-
ARROWHEAD PHARMACEUTICALS, INC.ARWRHealth Care
A clinical-stage biotechnology company pioneering RNA interference (RNAi) therapeutics to treat a wide array of genetic and chronic diseases by silencing…
$74.52 (as of 2026-07-21) · market cap $10.4B
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.47 (as of 2026-07-21) · market cap $1.6B
-
EDITAS MEDICINE INCEDITHealth Care
A pioneering CRISPR gene editing company developing in vivo therapies for genetic diseases, with lead candidate EDIT-401 targeting hyperlipidemia through LDL…
$2.89 (as of 2026-07-21) · market cap $443M
-
CRISPR THERAPEUTICS AGCRSPHealth Care
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and…
$48.15 (as of 2026-07-21) · market cap $4.6B
Not quite? Describe exactly what you want →
Peers are drawn from BNTC's enriched profile (the same similarity signal the chat uses for "companies like BNTC"). See the full profile: BENITEC BIOPHARMA INC (BNTC).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.